---
title: GNS Healthcare Blog | Value Based Care
description: Value Based Care |
---
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)
- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)
[](https://www.gnshealthcare.com/)
- Solutions
- [REFS Platform](https://www.gnshealthcare.com/refs-platform/)
- [Subpopulations](https://www.gnshealthcare.com/subpopulations/)
- [Value-based Drug Models](https://www.gnshealthcare.com/value-based-drug-models/)
- [Intervention Optimization](https://www.gnshealthcare.com/intervention-optimization/)
- [Customized Modeling](https://www.gnshealthcare.com/customized-modeling/)
- Who We Serve
- [Biopharma](https://www.gnshealthcare.com/biopharma/)
- [Health Plans](https://www.gnshealthcare.com/health-plans/)
- [Foundations](https://www.gnshealthcare.com/foundations/)
- Results
- [The Power of Causal Machine Learning](https://www.gnshealthcare.com/the-power-of-causal-machine-learning/)
- [Journal Articles](https://www.gnshealthcare.com/journal-articles/)
- [Posters](https://www.gnshealthcare.com/posters/)
- [News & Events](https://www.gnshealthcare.com/news/)
- [Blog](https://blog.gnshealthcare.com/)
- [In the News](https://www.gnshealthcare.com/news/#news)
- [Events](https://www.gnshealthcare.com/news/#events)
- [Press Releases](https://www.gnshealthcare.com/news/#press-releases)
- [GNS Precision Medicine Forum](https://www.gnshealthcare.com/gns-precision-medicine-forum/)
- About Us
- [Leadership](https://www.gnshealthcare.com/leadership/)
- [Board of Directors](https://www.gnshealthcare.com/board-of-directors/)
- [Strategic Advisory Board](https://www.gnshealthcare.com/strategic-advisory-board/)
- [Our Culture](https://www.gnshealthcare.com/culture/)
- [Careers](https://www.gnshealthcare.com/careers/)
- [Contact](https://www.gnshealthcare.com/contact/)
- [Request Info](https://info.gnshealthcare.com/request-info-website)
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)
## GNS Healthcare Blog
# GNS Healthcare Blog
## GNS Healthcare Primary Blog
By December 31, 1969
Aug 08
[](https://info.aitiabio.com/elusive-quest-for-value-in-healthcare)
## [Why Is It So Hard to Define Value in Healthcare?](https://info.aitiabio.com/elusive-quest-for-value-in-healthcare)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Value Based Care](https://info.aitiabio.com/topic/value-based-care), [AI](https://info.aitiabio.com/topic/ai), [Future](https://info.aitiabio.com/topic/future), [Healthcare](https://info.aitiabio.com/topic/healthcare), [Innovation](https://info.aitiabio.com/topic/innovation)
One of the more discussed topics in healthcare over the past decade has been the transition to a value-based system. No doubt it's a worthy goal, however the road has been a bumpy one at best. One of the toughest challenges has been getting a handle on the concept of value: how to define it, how optimize it, how to price it and what value means across the healthcare ecosystem.
While the conversation tends to take place in silos, moving to a value-based system means having conversations among all stakeholders. Bringing pharma, PBMs and payers to the same table to talk value is just one way to...
[Read More](https://info.aitiabio.com/elusive-quest-for-value-in-healthcare)
Nov 29
[](https://info.aitiabio.com/precision-medicine-no-longer-a-future-state)
## [Precision Medicine, No Longer a Future State](https://info.aitiabio.com/precision-medicine-no-longer-a-future-state)
By [Stacey Wasserman, Senior Vice President, Pharma Sales](https://info.aitiabio.com/author/stacey-wasserman-senior-vice-president-pharma-sales) | [Precision Medicine](https://info.aitiabio.com/topic/precision-medicine), [Value Based Care](https://info.aitiabio.com/topic/value-based-care), [AI](https://info.aitiabio.com/topic/ai), [Patient Centered Care](https://info.aitiabio.com/topic/patient-centered-care)
It always surprises me that when attending industry conferences, the discussions inevitably revolve around “the future” of artificial intelligence, machine learning and personalized medicine. My reaction? These innovations and practices aren’t impending, they’re already here.
[Read More](https://info.aitiabio.com/precision-medicine-no-longer-a-future-state)
Aug 23
[](https://info.aitiabio.com/value-based-contracts-end-journey-or-stop-along-the-way)
## [Are value-based contracts the end of the journey or just a stop along the way?](https://info.aitiabio.com/value-based-contracts-end-journey-or-stop-along-the-way)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Value Based Care](https://info.aitiabio.com/topic/value-based-care), [Drug Development](https://info.aitiabio.com/topic/drug-development), [Drug Discovery](https://info.aitiabio.com/topic/drug-discovery), [Real World Evidence](https://info.aitiabio.com/topic/real-world-evidence)
The drive to value-based care has become a significant issue for biopharma companies as more health plans request value-based contracts. According to McKinsey, over 200 of these innovative contracts have been publicly disclosed since 1994¹. The buzz around the biopharma industry is that these value-based contracts are the wave of the future. Although this trend is likely to continue in the immediate future, the shift to these types of contracts may not survive in the long term. Precision medicine may make them obsolete.
***Types of innovative biopharma contracts***
The two most prevalent types of...
[Read More](https://info.aitiabio.com/value-based-contracts-end-journey-or-stop-along-the-way)
Aug 09
[](https://info.aitiabio.com/real-world-evidence-drugs-development-value-based)
## [Real World Evidence: How It's Changing the Way Drugs are Developed and Valued](https://info.aitiabio.com/real-world-evidence-drugs-development-value-based)
By [Brielan Smiechowski, Director of Account Management](https://info.aitiabio.com/author/brielan-smiechowski-director-of-account-management) | [Value Based Analytics](https://info.aitiabio.com/topic/value-based-analytics), [Value Based Care](https://info.aitiabio.com/topic/value-based-care), [Real World Evidence](https://info.aitiabio.com/topic/real-world-evidence)
In the summer of 1996, two new prescription drugs, containing fenfluramine and phentermine, hit the market promising an easy way to lose weight. Use of the products skyrocketed and by mid 1997, almost two million people were taking them¹.
Just over a year later, in September of 1997, both products were abruptly pulled off the market amid growing concerns that use of the drugs may cause serious heart problems. The FDA found evidence that nearly one-third of those taking the drugs might develop a rare form of heart valve damage that could weaken the heart. Three deaths were linked to the use of...
[Read More](https://info.aitiabio.com/real-world-evidence-drugs-development-value-based)
Jun 21
[](https://info.aitiabio.com/3-keys-to-building-a-proactive-healthcare-system-using-ai)
## [3 Keys to Building a Proactive Healthcare System using AI](https://info.aitiabio.com/3-keys-to-building-a-proactive-healthcare-system-using-ai)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Interventions](https://info.aitiabio.com/topic/interventions), [Value Based Care](https://info.aitiabio.com/topic/value-based-care)
The U.S. health systems ranks 37th out of 191 countries in overall efficiency according to a recent ranking by the World Health Organization. WHO’s calculation includes a variety of indicators including population health, responsiveness, and fairness in financing and financial risk protection1.
The U.S ranks 43rd in life expectancy (79.7 years) behind other developed nations like Japan (84.74), Canada (81.76) and Germany (80.57)2. The U. S. does rank first in one category – total health expenditures, with an average per capita cost of $10,384, nearly twice the comparable country average of...
[Read More](https://info.aitiabio.com/3-keys-to-building-a-proactive-healthcare-system-using-ai)
May 31
[](https://info.aitiabio.com/data-and-ai-taking-center-stage-at-bio-2018)
## [Data and AI Taking Center Stage at BIO 2018](https://info.aitiabio.com/data-and-ai-taking-center-stage-at-bio-2018)
By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare) | [Big Data](https://info.aitiabio.com/topic/big-data), [Value Based Care](https://info.aitiabio.com/topic/value-based-care), [Conference](https://info.aitiabio.com/topic/conference), [Drug Discovery](https://info.aitiabio.com/topic/drug-discovery)
“AI is your rocket ship and data is the fuel."
Michael Dell said this to customers and partners at his annual conference, but the message will be one of the key takeaways for the 16,000 attendees expected at the 2018 BIO International Convention to be held in Boston next week. More than 5,000 companies from 70 different countries will be represented at the gathering that brings together biotechnology and pharma leaders for a week of intensive networking to discover new opportunities and promising partnerships. Discussions cover a wide spectrum of life science and application areas including...
[Read More](https://info.aitiabio.com/data-and-ai-taking-center-stage-at-bio-2018)
Mar 22
[](https://info.aitiabio.com/harnessing-new-traditional-data-to-discover-actionable-insights-with-ai)
## [Harnessing New & Traditional Data to Discover Actionable Insights with AI](https://info.aitiabio.com/harnessing-new-traditional-data-to-discover-actionable-insights-with-ai)
By [Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina](https://info.aitiabio.com/author/patrick-getzen-chief-data-and-analytics-officer-of-blue-cross-and-blue-shield-of-north-carolina) | [Big Data](https://info.aitiabio.com/topic/big-data), [Artificial Intelligence](https://info.aitiabio.com/topic/artificial-intelligence), [Value Based Care](https://info.aitiabio.com/topic/value-based-care)
*By Patrick Getzen, Chief Data and Analytics Officer of [Blue Cross and Blue Shield of North Carolina](https://www.bluecrossnc.com/)*
Clashes between the traditional and the novel are as old as time itself. Change is rarely welcomed, so anything new that comes along often faces a rough road to acceptance. However, that is not the case when it comes to the types of data that are now becoming available in the world of healthcare. The merging of new and traditional healthcare data promises to lead to a new era of discovery and offers significant benefits for patients, providers and payers.
[Read More](https://info.aitiabio.com/harnessing-new-traditional-data-to-discover-actionable-insights-with-ai)
### Subscribe to the GNS Newsletter
Search:
Search
### Follow Us:
### Recent Posts:
### Categories:
- [AI (29)](https://info.aitiabio.com/topic/ai)
- [Precision Medicine (21)](https://info.aitiabio.com/topic/precision-medicine)
- [Artificial Intelligence (20)](https://info.aitiabio.com/topic/artificial-intelligence)
- [Machine Learning (20)](https://info.aitiabio.com/topic/machine-learning)
- [Future (13)](https://info.aitiabio.com/topic/future)
- [Big Data (12)](https://info.aitiabio.com/topic/big-data)
- [Healthcare (11)](https://info.aitiabio.com/topic/healthcare)
### Twitter
[Tweets by @gnshealthcare](https://twitter.com/gnshealthcare)
**About GNS Healthcare**
By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals. We understand that in order to make precision medicine a reality, we need to discover and deliver insights that will cure disease and heal the healthcare system.
[Privacy Policy](https://www.gnshealthcare.com/privacy-policy)
**Contact Us**
196 Broadway
Cambridge, MA 02139
Email: [info@gnshealthcare.com](mailto:info@gnshealthcare.com)
Phone: 617.374.2300
- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)
© GNS Healthcare 561 Windsor St. A200, Somerville, MA 02143 | 617-374-2300